Evidence map›Paper›PMID 21585237›Full record

ArticleStem cells and development2011

Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung.

Andrew M Hoffman, Julia A Paxson, Melissa R Mazan, Airiel M Davis, Shivraj Tyagi, Shankar Murthy, Edward P Ingenito

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02985346 (Sun Yat-sen Memorial Hospital), which is not on this map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02985346 early_phase1unknown statusnot on this mapstarted 2017, after this paper: background citation

Sun Yat-sen Memorial Hospital

TypeinterventionalSponsorSun Yat-sen UniversityRan2017Enrolled100ConditionsIdiopathic Pulmonary HemosiderosisArmsBone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 117 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Host Defense againstJournal of immunology (Baltimore, Md. : 1950) · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cardiac NestinMolecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrew M HoffmanTufts University Cummings School of Veterinary Medicine, North Grafton, Massachusetts 01536, USA. andrew.hoffman@tufts.edu
Julia A Paxson
Melissa R Mazan
Airiel M Davis
Shivraj Tyagi
Shankar Murthy
Edward P Ingenito
Tufts University · USHarvard University · USBrigham and Women's Hospital · US

Funding

PREPARATION AND DISTRUBUTION OF ADULT STEM CELLS: HUMAN &RODENTP40RR017447 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI PROCKOP, DARWIN JOHNSON · 2003 to 2011
$8.9M
Pneumografting - a novel cell-based therapy for emphysemaR01HL090145 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI INGENITO, EDWARD P · 2007 to 2010
$2.4M
NCRR NIH HHS P40RR017447NHLBI NIH HHS HL090145-01
6 · The paper itself

Abstract

While multipotent mesenchymal stromal cells have been recently isolated from adult lung (L-MSCs), there is very limited data on their biological properties and therapeutic potential in vivo. How L-MSCs compare with bone marrow-derived MSCs (BM-MSCs) is also unclear. In this study, we characterized L-MSC phenotype, clonogenicity, and differentiation potential, and compared L-MSCs to BM-MSCs in vivo survival, retention, paracrine gene expression, and repair or elastase injury after transplantation. L-MSCs were highly clonogenic, frequently expressed aldehyde dehydrogenase activity, and differentiated into osteocytes, chondrocytes, adipocytes, myofibroblasts, and smooth muscle cells. After intravenous injection (2 h), L-MSCs showed greater survival than BM-MSCs; similarly, L-MSCs were significantly more resistant than BM-MSCs to anchorage independent culture (4 h) in vitro. Long after transplantation (4 or 32 days), a significantly higher number of CD45(neg) L-MSCs were retained than BM-MSCs. By flow cytometry, L-MSCs expressed more intercellular adhesion molecule-1 (ICAM-1), platelet derived growth factor receptor alpha (PDGFRα), and integrin α2 than BM-MSCs; these proteins were found to modulate endothelial adherence, directional migration, and migration across Matrigel in L-MSCs. Further, L-MSCs with low ICAM-1 showed poorer lung retention and higher phagocytosis in vivo. Compared with BM-MSCs, L-MSCs expressed higher levels of several transcripts (e.g., Ccl2, Cxcl2, Cxcl10, IL-6, IL-11, Hgf, and Igf2) in vitro, although gene expression in vivo was increased by L-MSCs and BM-MSCs equivalently. Accordingly, both L-MSCs and BM-MSCs reduced elastase injury to the same extent. This study demonstrates that tissue-specific L-MSCs possess mechanisms that enhance their lung retention after intravenous transplantation, and produce substantial healing of elastase injury comparable to BM-MSCs.

Indexed as

Mesenchymal Stem Cell TransplantationParacrine CommunicationWound HealingAnimalsBone Marrow CellsCell AdhesionCell DifferentiationCell MovementCell ProliferationCells, CulturedEndothelial CellsFemaleGene Expression RegulationLungLung InjuryMaleMembrane ProteinsPancreatic Elastase

Identifiers

PMID21585237
PMCPMC3182034
OpenAlexW2114651025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.